Case Report
BibTex RIS Cite

Asemptomatik Seyreden Mesane Paraganglioması

Year 2026, Volume: 18 Issue: 1 , 59 - 64 , 28.04.2026
https://izlik.org/JA29FD59UM

Abstract

Giriş: Nöral krest tömörü olan feokromasitoma adrenal dışı yerleşimli olduğunda paraganlioma adını almaktadır. Adrenal dışı yerleşimlerden biri de mesane olup mesane tümörlerinin %0,06’sını teşkil etmektedir. Biz de mesane yerleşimli insidental olarak saptanan paraganlioma olgusunu literatür eşliğinde sunmayı amaçladık.
Vaka: 68 yaşında erkek hasta benign prostat hiperplazisi tanısı ile takibi esnasında görüntülemede mesanede insidental kitle saptandı ve rezeksiyon sonrası patolojik sonucu paraganlioma olarak değerlendirildi. Hastanın operasyon sonrası takiplerinde nüks gözlenmedi.
Tartışma: Mesanede insidental saptanan kitlelerde paraganlioma da ön tanılar içinde yer almalı; operasyon esnasında ve sonrasında normal mesane tümörü takibine ek olarak ketakolamin düzeyleri ve farklı görüntüleme tetkiklerinin yapılması kanısındayız. Özellikle operasyon esasında; bizim vakamızda gelişmemesine rağmen adrenal krizi açısından hazırlıklı olunması gerekmektedir.

References

  • Referans 1. Zimmerman IJ, Bıron RE, Macmahon HE. Pheochromocy toma of the urinary bladder. N Engl J Med 1953;2:249:25-6.
  • Referans 2. Onıshı T, Yuko S, Shigenori Y, Yoshiki S. Pheochromocytoma of the urinary bladder without typical symptoms. International journal of urology. 2003;10(7):398-400.
  • Referans 3. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, Heerden JA et al. Benign para gangliomas: clinical presentation and treatment outco mes in 236 patients. J Clin Endocrinol Metab 2001; 86: 5210–5216.
  • Referans 4. Doran F, Varınlı S, Bayazıt Y, Bal N, Ozdemir S. Pheochromocytoma of the urinary bladder: Case report. Apmis. 2002;110(10):733-736.
  • Referans 5. Sheps SG, Jiang NS, Klee GG, Van Heerden JA. Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 1990;65:88–95.
  • Referans 6. Bravo EL, Tarazi RC, Gifford RW, Steward BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnos tic and pathophysiologic implications. N Engl J Med 1979; 301: 682–686.
  • Referans 7. Kudva YC, Sawka AM, Young WF Jr. The laboratorydiagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003; 88:4533-9.
  • Referans 8. Flanigan RC, Wittmann RP, Huhn RG, Davis CJ. Malignant pheochromocytoma of the urinary bladder. Urology. 1980; 16: 386–8.
  • Referans 9. Thrasher JB, Rajan RR, Perez LM, Humphrey PA, Anderson EE. Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology. 1993; 41: 435-9
  • Referans 10. Ongün Ş, Mungan MU, Seçil M, Yörükoğlu K, Tuna EB. Mesanenin Sporadik Paraganglioması. DEÜ Tıp Fakültesi Dergisi. 2011;1:51-3.

Asymptomatic Paraganglioma of Bladder

Year 2026, Volume: 18 Issue: 1 , 59 - 64 , 28.04.2026
https://izlik.org/JA29FD59UM

Abstract

Introduction: Pheochromocytoma, a neural crest tumour, is called paraganlioma when it is located outside the adrenal gland. One of the non-adrenal sites is the bladder and it accounts for 0.06% of bladder tumours. We aimed to present an incidental case of paraganlioma located in the bladder in the light of the literature.
Case: A 68-year-old male patient was diagnosed with benign prostatic hyperplasia and an incidental bladder mass was detected on imaging and the pathological result after resection was evaluated as paraganlioma. No recurrence was observed at postoperative follow-up.
Discussion: We believe that paraganlioma should be included in the preliminary diagnosis of incidental bladder masses and ketacholamine levels, and various imaging tests should be performed during and after surgery in addition to normal bladder tumour follow-up. Especially during surgery, one should be prepared for an adrenal crisis, although it did not develop in our case.

References

  • Referans 1. Zimmerman IJ, Bıron RE, Macmahon HE. Pheochromocy toma of the urinary bladder. N Engl J Med 1953;2:249:25-6.
  • Referans 2. Onıshı T, Yuko S, Shigenori Y, Yoshiki S. Pheochromocytoma of the urinary bladder without typical symptoms. International journal of urology. 2003;10(7):398-400.
  • Referans 3. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, Heerden JA et al. Benign para gangliomas: clinical presentation and treatment outco mes in 236 patients. J Clin Endocrinol Metab 2001; 86: 5210–5216.
  • Referans 4. Doran F, Varınlı S, Bayazıt Y, Bal N, Ozdemir S. Pheochromocytoma of the urinary bladder: Case report. Apmis. 2002;110(10):733-736.
  • Referans 5. Sheps SG, Jiang NS, Klee GG, Van Heerden JA. Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 1990;65:88–95.
  • Referans 6. Bravo EL, Tarazi RC, Gifford RW, Steward BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnos tic and pathophysiologic implications. N Engl J Med 1979; 301: 682–686.
  • Referans 7. Kudva YC, Sawka AM, Young WF Jr. The laboratorydiagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003; 88:4533-9.
  • Referans 8. Flanigan RC, Wittmann RP, Huhn RG, Davis CJ. Malignant pheochromocytoma of the urinary bladder. Urology. 1980; 16: 386–8.
  • Referans 9. Thrasher JB, Rajan RR, Perez LM, Humphrey PA, Anderson EE. Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology. 1993; 41: 435-9
  • Referans 10. Ongün Ş, Mungan MU, Seçil M, Yörükoğlu K, Tuna EB. Mesanenin Sporadik Paraganglioması. DEÜ Tıp Fakültesi Dergisi. 2011;1:51-3.
There are 10 citations in total.

Details

Primary Language Turkish
Subjects Urology
Journal Section Case Report
Authors

Hayriye Canik Yaşar 0000-0003-3633-8735

Adem Yaşar 0000-0003-4029-1896

Submission Date December 17, 2024
Acceptance Date March 14, 2025
Publication Date April 28, 2026
IZ https://izlik.org/JA29FD59UM
Published in Issue Year 2026 Volume: 18 Issue: 1

Cite

APA Canik Yaşar, H., & Yaşar, A. (2026). Asemptomatik Seyreden Mesane Paraganglioması. International Journal of Tokat Medical Sciences, 18(1), 59-64. https://izlik.org/JA29FD59UM
AMA 1.Canik Yaşar H, Yaşar A. Asemptomatik Seyreden Mesane Paraganglioması. International Journal of Tokat Medical Sciences. 2026;18(1):59-64. https://izlik.org/JA29FD59UM
Chicago Canik Yaşar, Hayriye, and Adem Yaşar. 2026. “Asemptomatik Seyreden Mesane Paraganglioması”. International Journal of Tokat Medical Sciences 18 (1): 59-64. https://izlik.org/JA29FD59UM.
EndNote Canik Yaşar H, Yaşar A (April 1, 2026) Asemptomatik Seyreden Mesane Paraganglioması. International Journal of Tokat Medical Sciences 18 1 59–64.
IEEE [1]H. Canik Yaşar and A. Yaşar, “Asemptomatik Seyreden Mesane Paraganglioması”, International Journal of Tokat Medical Sciences, vol. 18, no. 1, pp. 59–64, Apr. 2026, [Online]. Available: https://izlik.org/JA29FD59UM
ISNAD Canik Yaşar, Hayriye - Yaşar, Adem. “Asemptomatik Seyreden Mesane Paraganglioması”. International Journal of Tokat Medical Sciences 18/1 (April 1, 2026): 59-64. https://izlik.org/JA29FD59UM.
JAMA 1.Canik Yaşar H, Yaşar A. Asemptomatik Seyreden Mesane Paraganglioması. International Journal of Tokat Medical Sciences. 2026;18:59–64.
MLA Canik Yaşar, Hayriye, and Adem Yaşar. “Asemptomatik Seyreden Mesane Paraganglioması”. International Journal of Tokat Medical Sciences, vol. 18, no. 1, Apr. 2026, pp. 59-64, https://izlik.org/JA29FD59UM.
Vancouver 1.Hayriye Canik Yaşar, Adem Yaşar. Asemptomatik Seyreden Mesane Paraganglioması. International Journal of Tokat Medical Sciences [Internet]. 2026 Apr. 1;18(1):59-64. Available from: https://izlik.org/JA29FD59UM